iDtheinvestordatabase
Home / Directory / BroadOak Capital Partners
Likely active: portfolio news Apr 2026 Verified 5 Nov 2026

BroadOak Capital Partners

Life sciences focused firm, filing from Bethesda, MD, that provides growth capital through direct investment and investment banking services to companies in life science tools, services, manufacturing, pharma tech and health tech.

Type
VC firm
Location
Bethesda, Maryland, United States
Stages
Growth
Backs
Biotech and pharma, B2B software
Sectors
Biotech, Healthtech and life sciences, Industrial
Fund size / AUM
$11.2M Broadoak Capital 2018b (Form D offering, 2021); $357.9M gross private fund assets (Form ADV; private funds: 10, of which venture capital: 1)
Latest fund or filing
11 Oct 2022
Portfolio mix
Biotech and pharma 64%; B2B software 16%; Hardware 8%; Medtech and digital health 8%; Consumer products 4% (n=25)

Contacts on file

For BroadOak Capital Partners, the paid file holds: 8 named decision-makers with roles; LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Lanterne Dxinsphero squarequartzyOpentronsabtherx cures

Sources

Last checked 5 Nov 2026. Is something wrong? Tell us.

Appears in 23 lists